Where do new medicines start? They start in the lab, where scientists study the biological mechanisms that contribute to good health or, when they go awry, cause disease. Beaker highlights interesting science, Sanford-Burnham Medical Research Institute and our supporters.
Beaker's Latest Posts
On March 3, 2015, celebrated journalist and associate director of MIT’s Graduate Program in Science Writing Seth Mnookin joined Sanford-Burnham scientist Dr. Hudson Freeze, director of our Human Genetics Program, for a special lecture hosted at the Sanford Children’s Health Research Center.
Understanding the molecular and genetic changes that trigger diet-induced heart disease can lead to new drugs for lipotoxic cardiomyopathy
6th Annual Rare Disease Day symposium gathers patients, clinicians and researchers to discuss sugar therapy
2015 Rare Disease Day presents "Treating Disease with Sugar"
A new compound shows promise as a novel antiplatelet therapy for better treatment of heart attack and ischemic stroke
Melanoma tumors use the amino acid glutamine in an unusual way to gain extra energy for growth and survival
Log in to leave a comment